Isracann Biosciences (IPOT.C) did more work in three months than some companies did in a year
There’s a lot going on underneath the surface with Isracann Biosciences (IPOT.C). A year in review won’t be much, mostly because this company hasn’t been public for a year. Instead, it’s more like a quarter-in-review, as the company only rolled into Atlas Blockchain, going public on the CSE (and OTC exchange as ISCNF) in October of 2019, but what makes this (and them) noteworthy is what they’ve managed to build for themselves in such a short timespan.
